BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17364882)

  • 41. Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action.
    Penning TM
    Hum Reprod Update; 2003; 9(3):193-205. PubMed ID: 12861966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porcine carbonyl reductase. structural basis for a functional monomer in short chain dehydrogenases/reductases.
    Ghosh D; Sawicki M; Pletnev V; Erman M; Ohno S; Nakajin S; Duax WL
    J Biol Chem; 2001 May; 276(21):18457-63. PubMed ID: 11279087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta.
    Atalla A; Maser E
    Chem Biol Interact; 2001 Jan; 130-132(1-3):737-48. PubMed ID: 11306090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of a novel translational repressor of the steroid-inducible 3 alpha-hydroxysteroid dehydrogenase/carbonyl reductase gene in Comamonas testosteroni.
    Xiong G; Martin HJ; Maser E
    J Biol Chem; 2003 Nov; 278(48):47400-7. PubMed ID: 12975360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The aldo-keto reductase superfamily homepage.
    Hyndman D; Bauman DR; Heredia VV; Penning TM
    Chem Biol Interact; 2003 Feb; 143-144():621-31. PubMed ID: 12604248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostaglandin-E2 9-reductase from corpus luteum of pseudopregnant rabbit is a member of the aldo-keto reductase superfamily featuring 20 alpha-hydroxysteroid dehydrogenase activity.
    Wintergalen N; Thole HH; Galla HJ; Schlegel W
    Eur J Biochem; 1995 Nov; 234(1):264-70. PubMed ID: 8529651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) - an in silico approach.
    Ebert B; Kisiela M; Maser E
    Drug Metab Rev; 2016 May; 48(2):183-217. PubMed ID: 27362327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chinese hamster monomeric carbonyl reductases of the short-chain dehydrogenase/reductase superfamily.
    Miura T; Nishinaka T; Takama M; Murakami M; Terada T
    Chem Biol Interact; 2009 Mar; 178(1-3):110-6. PubMed ID: 18983989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine.
    Schlegel BP; Ratnam K; Penning TM
    Biochemistry; 1998 Aug; 37(31):11003-11. PubMed ID: 9692994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
    Stambergova H; Skarydova L; Dunford JE; Wsol V
    Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.
    Skarydová L; Wsól V
    Drug Metab Rev; 2012 May; 44(2):173-91. PubMed ID: 22181347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology.
    Oppermann U
    Annu Rev Pharmacol Toxicol; 2007; 47():293-322. PubMed ID: 17009925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of two isoforms of mouse 3(17)alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase family.
    Ishikura S; Usami N; Nakajima S; Kameyama A; Shiraishi H; Carbone V; El-Kabbani O; Hara A
    Biol Pharm Bull; 2004 Dec; 27(12):1939-45. PubMed ID: 15577209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin.
    Skarydová L; Skarka A; Novotná R; Zivná L; Martin HJ; Wsól V; Maser E
    Toxicology; 2009 Oct; 264(1-2):52-60. PubMed ID: 19635524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man.
    Wsol V; Szotakova B; Martin HJ; Maser E
    Toxicology; 2007 Sep; 238(2-3):111-8. PubMed ID: 17618725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation.
    Penning TM
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):46-56. PubMed ID: 21272640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13.
    Vergnes L; Phan J; Stolz A; Reue K
    J Lipid Res; 2003 Mar; 44(3):503-11. PubMed ID: 12562828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aldo-keto reductase (AKR) superfamily: genomics and annotation.
    Mindnich RD; Penning TM
    Hum Genomics; 2009 Jul; 3(4):362-70. PubMed ID: 19706366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning, expression and characterization of a novel short-chain dehydrogenase/reductase (SDRx) in Comamonas testosteroni.
    Gong W; Xiong G; Maser E
    J Steroid Biochem Mol Biol; 2012 Mar; 129(1-2):15-21. PubMed ID: 21111045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic mechanisms in the reduction of aldehydes and ketones catalyzed by rabbit liver aldehyde reductases and hydroxysteroid dehydrogenases.
    Sawada H; Hara A; Nakayama T; Hayashibara M
    J Biochem; 1982 Jul; 92(1):185-91. PubMed ID: 6749832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.